Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507325 · ClinicalTrials.gov registry record
Sample Collection From Melanoma Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 131
- Enrollment target
NCT00507325: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00507325 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507325 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 131 participants
- Enrollment target
Study Summary
The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.
Interventions
- PROCEDURE Blood Sample
- PROCEDURE Tumor Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2006-06-13 |
| Est. Completion | 2022-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00507325
The ClinicalTrials.gov registry entry for NCT00507325 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Sample is the first listed.
NCT00507325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00507325 about?
NCT00507325 is a clinical study titled "Sample Collection From Melanoma Patients". The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find w...
What is the current status of trial NCT00507325?
This trial is currently terminated. The enrollment target is 131 participants. The study started on 2006-06-13. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT00507325?
The interventions under investigation include: Blood Sample (PROCEDURE), Tumor Sample (PROCEDURE).
Who is sponsoring clinical trial NCT00507325?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.